Table 3.
Kaplan–Meier estimates of 12-mo ART program LTFU by covariates reported by LTFU definition
| Characteristics | Definition A | Variation A1 | Variation A2 | Variation A3 | Variation A4 | Site defined |
|---|---|---|---|---|---|---|
| Gender | ||||||
| Male | 17.0 | 15.8 | 14.6 | 13.0 | 10.6 | 13.7 |
| Female | 14.8 | 13.8 | 12.7 | 10.5 | 8.5 | 12.2 |
| Age (yr) | ||||||
| 16–24 | 22.1 | 20.2 | 19.0 | 15.1 | 12.2 | 17.3 |
| 25–34 | 15.6 | 14.4 | 13.6 | 11.3 | 9.3 | 12.4 |
| 35–44 | 14.6 | 13.6 | 12.5 | 10.9 | 8.8 | 12.2 |
| 45+ | 15.4 | 14.3 | 13.0 | 11.1 | 8.6 | 13.0 |
| Baseline CD4 (cells/uL) | ||||||
| <50 | 16.4 | 15.4 | 13.2 | 13.7 | 11.4 | 13.7 |
| 50–199 | 13.8 | 12.8 | 12.0 | 9.7 | 8.0 | 11.3 |
| ≥200 | 17.7 | 16.0 | 15.4 | 12.4 | 10.2 | 12.9 |
| Year of initiation | ||||||
| 2002 and 2003 | 1.1 | 1.1 | 1.1 | 0.8 | 0.1 | 1.0 |
| 2004 | 9.0 | 9.0 | 7.5 | 6.4 | 6.0 | 7.8 |
| 2005 | 10.8 | 10.8 | 9.1 | 7.8 | 7.3 | 8.3 |
| 2006 | 14.0 | 13.7 | 11.8 | 9.6 | 8.5 | 9.9 |
| 2007 | 26.7 | 20.7 | 23.8 | 21.4 | 13.3 | 21.6 |
Abbreviations: ART, antiretroviral therapy; LTFU, loss to follow-up; CD4, cluster of differentiation 4.